Last deal

$1.4M
Local Amount - EUR 1.28M

Amount

Seed

Stage

11.05.2023

Date

1

all rounds

$1.4M

Total amount

date founded

Financing round

General

About Company
Oniria Therapeutics develops precision oncology therapies to eliminate dormant tumor cells.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2021

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The Barcelona-based biotech company, founded in 2021, focuses on developing first-in-class drugs in precision oncology. Their flagship product activates TET2, an epigenetic enzyme, to counteract cancer resistance and combat disease relapse. By modulating dormant cancer cells, Oniria Therapeutics aims to exploit vulnerabilities and help patients prolong their lives and potentially cure cancer.
Contacts
Similar Companies
1000
Ziopharm oncology

Ziopharm oncology

ZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

9

total raised

$293.39M
Neon Therapeutics

Neon Therapeutics

Neon Therapeutics develops personalized vaccines and autologous T-cell therapies for cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

3

total raised

$161M
Prelude Therapeutics

Prelude Therapeutics

Prelude Therapeutics develops novel therapies to target key drivers of cancer cell growth, survival, and resistance.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Wilmington, DE, USA

total rounds

4

total raised

$147M
Cybrexa Therapeutics

Cybrexa Therapeutics

Cybrexa Therapeutics is developing a new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New Haven, CT, USA

total rounds

5

total raised

$44.4M

Financials

Funding Rounds
1
1

Number of Funding Rounds

$1.4M

Money Raised

Their latest funding was raised on 11.05.2023. Their latest investor Fundacion Botin. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
11.05.2023
5
$1.4M
Local Amount - EUR 1.28M
Fundacion Botin

Fundacion Botin

The Botín Foundation is a private charitable foundation that invests in new development to generate creative talent betting forms.

Sector

Software and Computer Services

Subsector

Consumer Digital Services

Location

Santander, Cantabria, Spain

count Of Investments

5
Co-Investors
Investors
5
1

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
Fundacion Botin

Fundacion Botin

The Botín Foundation is a private charitable foundation that invests in new development to generate creative talent betting forms.

Sector

Software and Computer Services

Subsector

Consumer Digital Services

Location

Santander, Cantabria, Spain

count Of Investments

5

Torres Quevedo

count Of Investments

1

Startup Capital Ventures and ACCIÓ

The company is a collaboration between the European Commission and a Catalan agency.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Association

count Of Investments

1

Activity

Recent News
1